Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$12.62 - $24.47 $22.8 Million - $44.2 Million
-1,807,742 Reduced 47.15%
2,026,112 $49.6 Million
Q1 2023

May 12, 2023

BUY
$12.98 - $17.1 $7.8 Million - $10.3 Million
600,624 Added 18.58%
3,833,854 $51.6 Million
Q4 2022

Feb 13, 2023

BUY
$13.92 - $17.0 $45 Million - $55 Million
3,233,230 New
3,233,230 $50.3 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Grandeur Peak Global Advisors, LLC Portfolio

Follow Grandeur Peak Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.